Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.

Ureteral Stent Length and Patient Symptoms

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00288457
Recruitment Status : Terminated (Because no staff to consent or enroll subjects)
First Posted : February 8, 2006
Last Update Posted : December 24, 2013
Sponsor:
Information provided by (Responsible Party):
John G Pattaras, MD, Emory University

Tracking Information
First Submitted Date February 6, 2006
First Posted Date February 8, 2006
Last Update Posted Date December 24, 2013
Study Start Date February 2006
Primary Completion Date Not Provided
Current Primary Outcome Measures Not Provided
Original Primary Outcome Measures Not Provided
Change History Complete list of historical versions of study NCT00288457 on ClinicalTrials.gov Archive Site
Current Secondary Outcome Measures Not Provided
Original Secondary Outcome Measures Not Provided
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title Ureteral Stent Length and Patient Symptoms
Official Title Not Provided
Brief Summary The Study of whether or not Ureteral Stent Length affects patient comfort after electro-shock wave treatment for kidney stones.
Detailed Description Patients undergoing electro shock wave for treatment of kidney stones are randomized to long or short stent length after signing an informed consent prior to their surgery. They keep a pain diary and medication diary for a two week period after the stent is placed. These are turned in at the two week post-op visit. Patients also complete a quality of life and urinary symptom score questionnaire pre and post operatively.
Study Type Observational
Study Design Time Perspective: Prospective
Target Follow-Up Duration Not Provided
Biospecimen Not Provided
Sampling Method Probability Sample
Study Population Male or female over 18 years of age, will be receiving electro-shock wave therapy for kidney stones
Condition Kidney Stones
Intervention Device: Ureteral Stent
Ureteral stents are not investigatory but rather part of standard of care. In this study, we were interested in having patients fill out pre and post-operative questionnaires so that we could compare their symptoms with the length of their ureter and the stent placed.
Study Groups/Cohorts Not Provided
Publications * Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status Terminated
Actual Enrollment
 (submitted: March 27, 2012)
1
Original Enrollment
 (submitted: February 6, 2006)
75
Actual Study Completion Date October 2006
Primary Completion Date Not Provided
Eligibility Criteria

Inclusion Criteria: Male or female over 18 years of age, will be receiving electro-shock wave therapy for kidney stones -

Exclusion Criteria:Under 18 years of age, inability to give informed consent

-

Sex/Gender
Sexes Eligible for Study: All
Ages 18 Years and older   (Adult, Older Adult)
Accepts Healthy Volunteers No
Contacts Contact information is only displayed when the study is recruiting subjects
Listed Location Countries Not Provided
Removed Location Countries United States
 
Administrative Information
NCT Number NCT00288457
Other Study ID Numbers 0758-2003
Has Data Monitoring Committee Not Provided
U.S. FDA-regulated Product Not Provided
IPD Sharing Statement Not Provided
Responsible Party John G Pattaras, MD, Emory University
Study Sponsor Emory University
Collaborators Not Provided
Investigators
Principal Investigator: John G Pattaras, MD Emory University
PRS Account Emory University
Verification Date December 2013